Skip to main content
Premium Trial:

Request an Annual Quote

Mary Tanner, Stephen Oldfield, Jan Hughes, William Murray, Catherine Burzik, Carl Hull, Stephen Kondor, Peter Dansky, John Lisle, and Samraat Raha

Premium

Evotec OAI said last week that Mary Tanner has been elected to the company’s supervisory board. Tanner has 22 years of senior-level management experience in healthcare and consumer products at Lehman Brothers and Bear Stearns, Evotec said. Tanner retired from Bear Stearns in 2004, and founded Life Sciences Partners, a healthcare investment and advisory firm. Tanner obtained a degree from Harvard University in 1973 in philosophy and related fields, Evotec said.


Stephen Oldfield has left his position as vice president of worldwide marketing for Molecular Devices, Inside Bioassays, PGx Reporter’s sister publication, has learned. A company spokesperson declined to provide details regarding Oldfield’s departure. Molecular Devices said it has named Jan Hughes as the new vice president of worldwide marketing. Hughes previously was VP of product development for Molecular Devices’ high-throughput electrophysiology division.


William Murray has been appointed division president, molecular biology at Applied Biosystems, the company said. He takes over for Catherine Burzik, the current president of Applied Biosystems, who had been leading the division since the company announced a restructuring last summer. Murray most recently served as group president of respiratory technologies for Viasys Healthcare. He also has held executive positions at Medtronic. Applied Biosystems also announced other management appointments in the molecular biology division, including naming Carl Hull to the post of vice president and general manager, real-time PCR systems and microarrays. Stephen Kondor was named vice president and general manager, genetic analysis, and Peter Dansky was named senior director and general manager, core PCR and DNA synthesis.


Inpharmatica has appointed John Lisle as chief executive officer, the company said this week. Lisle recently served as chief executive officer of Profile Therapeutics and previously held a variety of commercial roles at GlaxoSmithKline and Astra Zeneca. The current chief executive will stay with the company as chief scientific officer


Samraat Raha, former vice president of GE Healthcare’s CodeLink microarray product line, has joined Agilent Technologies’ Life Science and Chemical Analysis business unit as vice president of field operations for the Americas. Raha manages sales and marketing for the Americas, including all LSCA markets (Integrated Biology, Pharmaceutical Analysis, Chemical Analysis, Consumables & Services). Raha joined Amersham before the company’s acquisition by General Electric and worked there for almost two years before joining Agilent. Previously, he was chief business officer for EraGen of Madison, Wis., and prior to that, he was vice president of discovery services and bioreagents for Incyte Genomics.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.